Show simple item record

dc.contributor.authorMathew, Anuja
dc.contributor.authorTerajima, Masanori
dc.contributor.authorWest, Kim
dc.contributor.authorGreen, Sharone
dc.contributor.authorRothman, Alan L.
dc.contributor.authorEnnis, Francis A.
dc.contributor.authorKennedy, Jeffrey S.
dc.date2022-08-11T08:09:01.000
dc.date.accessioned2022-08-23T16:15:44Z
dc.date.available2022-08-23T16:15:44Z
dc.date.issued2005-02-09
dc.date.submitted2008-11-10
dc.identifier.citation<p>J Immunol. 2005 Feb 15;174(4):2212-9.</p>
dc.identifier.issn0022-1767 (Print)
dc.identifier.doi10.4049/jimmunol.174.4.2212
dc.identifier.pmid15699154
dc.identifier.urihttp://hdl.handle.net/20.500.14038/34159
dc.description.abstractMurine T cell epitopes against vaccinia virus (VV) have not been characterized to date in part due to the large and complex genome of VV. We have identified and characterized two CD8+ T cell epitopes on the A47L (modified VV Ankara strain (MVA)-029) and J6R (MVA-043) proteins of VV that are Db and Kb restricted, respectively. Following i.p. immunization with VV New York City Board of Health (NYCBH) strain, MVA-029 peptide-stimulated splenocytes secreted IFN-gamma from 7 days to 7 mo postimmunization, and virus-stimulated effectors were also able to lyse MVA-029-pulsed target cells at the same time points. In contrast, MVA-043 peptide-stimulated splenocytes secreted very low levels of IFN-gamma only at day 7 but maintained the ability to lyse target cells up to 2 mo postimmunization. Both MVA-029 and MVA-043 peptide-stimulated lymph node cells degranulated similarly as assessed by Ag-induced CD107 expression. T cell responses to whole-virus stimulation remained robust and steady during the acute and memory T cell response to VV. Identification of T cell epitopes on VV will enable further studies to increase our understanding of the role of CD8+ T cells in VV infection and assist in the design of new protective strategies.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15699154&dopt=Abstract ">Link to article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.4049/jimmunol.174.4.2212
dc.subjectAmino Acid Sequence; Animals; Cell Degranulation; Cell Line, Tumor; Cells, Cultured; *Cytotoxicity Tests, Immunologic; Epitopes, T-Lymphocyte; H-2 Antigens; Injections, Intraperitoneal; Interferon Type II; Kinetics; Male; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Peptide Fragments; T-Lymphocytes, Cytotoxic; Vaccinia virus; Viral Vaccines
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleIdentification of murine poxvirus-specific CD8+ CTL epitopes with distinct functional profiles
dc.typeJournal Article
dc.source.journaltitleJournal of immunology (Baltimore, Md. : 1950)
dc.source.volume174
dc.source.issue4
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/819
dc.identifier.contextkey663947
html.description.abstract<p>Murine T cell epitopes against vaccinia virus (VV) have not been characterized to date in part due to the large and complex genome of VV. We have identified and characterized two CD8+ T cell epitopes on the A47L (modified VV Ankara strain (MVA)-029) and J6R (MVA-043) proteins of VV that are Db and Kb restricted, respectively. Following i.p. immunization with VV New York City Board of Health (NYCBH) strain, MVA-029 peptide-stimulated splenocytes secreted IFN-gamma from 7 days to 7 mo postimmunization, and virus-stimulated effectors were also able to lyse MVA-029-pulsed target cells at the same time points. In contrast, MVA-043 peptide-stimulated splenocytes secreted very low levels of IFN-gamma only at day 7 but maintained the ability to lyse target cells up to 2 mo postimmunization. Both MVA-029 and MVA-043 peptide-stimulated lymph node cells degranulated similarly as assessed by Ag-induced CD107 expression. T cell responses to whole-virus stimulation remained robust and steady during the acute and memory T cell response to VV. Identification of T cell epitopes on VV will enable further studies to increase our understanding of the role of CD8+ T cells in VV infection and assist in the design of new protective strategies.</p>
dc.identifier.submissionpathgsbs_sp/819
dc.contributor.departmentCenter for Infectious Disease and Vaccine Research
dc.source.pages2212-9


This item appears in the following Collection(s)

Show simple item record